Skip to main content
Equibles

Vommel Devan

Analyst

Guggenheim Securities

Equibles does not estimate personal net worth.

About Vommel Devan

Vommel Devan is recorded as Analyst at Guggenheim Securities. Vommel Devan has spoken on 1 earnings call across 1 company, most recently for Pfizer Inc on February 3, 2026. The companies whose calls Vommel Devan spoke on are classified in the Healthcare sector.

Vommel Devan on recent calls

“So, just maybe building off this, Chris, you just talked a little bit about this in the prior question around down titration in Phase 3. Can you just elaborate a little bit more on that, kind of how you're designing your Phase 3s and allowing for flexibility of the patient, maybe dealing with any sort of side effects?”
Analyst — Guggenheim Securities, Pfizer Inc Q4 FY2025 Earnings Call ·

Affiliation history

  • Guggenheim Securities

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity